Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 15

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 15
---
                                                                                                                                                                                                                                                                                                                                                                                                                              
 •WellPoint Health Networks, Inc., Director (2003-2004)                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Incoming Independent Chair of the Board(1) 
 Age:69                                     
 Director Since:2004                        
 Committees:                                
 Compensation and Talent (Chair)            
 Finance                                    
 Skills, Experiencesand Attributes:         
 •COO/Executive Leadership                  
 •Finance/Capital Markets                   
 •Technology                                
 •Diversity                                 
 Education:                                 
 B.S., University of Arizona                |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

(1) The Board has appointed Ramiro Peru as the incoming independent Chair of the Board beginning on the date of the Annual Meeting.

#### 2025 Proxy Statement21

#### Corporate Governance

#### Board’s Role and Responsibilities
Our business is overseen by the Board. The Board has responsibility for establishing broad corporate policies and for our overall performance. We believe the only results worth achieving are those achieved with integrity and a commitment to excellence. Accordingly, we have long recognized the importance of, and have placed a high priority upon, having good corporate governance measures in place.

#### Board Role in Risk Oversight
Our management is responsible for the day-to-day management of the risks facing the Company, including the risk management process, controls and oversight. The Board as a whole has responsibility for risk oversight. We have an Enterprise Risk Council to oversee our enterprise risk management (“ERM”) program. The Enterprise Risk Council is composed of members of our leadership team and the Chief Risk Officer, who serves as the head of the ERM function and reports to the Audit Committee of the Board, with annual updates to the full Board. Additionally, the full Board regularly reviews risks that may be material to the Company, including those detailed in reports from the committees of the Board and as disclosed in the Company’s quarterly and annual reports filed with the SEC. While the Board has established committees designated for various oversight functions, it is common practice for the Board and committees to collaborate on overlapping issues.

| Board                                                                                                                                                                                                                                                                                                                                          
 •Oversees management’s processes by which they identify, assess, monitor and manage the Company’s exposure to major risks to determine whether these processes are functioning as intended and are consistent with our business objectives and strategies and comply with applicable laws, regulations, contractual requirements and policies. 
 •Reviews certain risk tolerance levels and action plans regarding major risks.                                                                                                                                                                                                                                                                 
 •Reviews the Own Risk and Solvency Assessment Summary Report, filed annually with state insurance departments.                                                                                                                                                                                                                                 
 •Receives periodic reports from its committees